DLH to Pioneer Medical and Healthcare Technology Innovations for Veterans
October 06 2022 - 8:00AM
DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the
“Company”), a leading provider of innovative health
research services and solutions to federal agencies, today
announced it has been awarded an Indefinite Delivery/Indefinite
Quantity (ID/IQ) multiple award contract to augment the Department
of Veteran Affairs’ (“VA”) efforts to design, develop, and test
innovations in healthcare.
As part of the Accelerating VA Innovation and Learning (“AVAIL”)
contract, DLH will compete with 17 prime awardees for individual
task orders across five task categories: personalized healthcare,
data transformation, digital care, immersive technology (extended
reality solutions), and care and service delivery. The
multiple-award contract consists of a five-year base period and has
a $650 million ceiling, in aggregate, for all awardees. Specific
values will be allocated to contractors as task orders are competed
and awarded.
“Ensuring Veterans have access to the highest quality care is
central to the DLH mission, and this contract enables our company
to connect the VA with the emerging tools, advanced processes,
digital solutions, and data transformation required to support
their long-standing tradition as a pioneer in medical innovation,”
said Jackie Everett, DLH Chief Growth Officer. “DLH will leverage
our expertise in applied research, genomics, synthetic data
modeling, augmented and virtual reality, digital health tools, and
synthetic data modeling to support the design, development and
testing of the next generation of medical devices needed by the VA
as it accelerates its pace of modernization.”
“We are honored for this opportunity to expand upon our
long-standing relationship with the Department of Veterans Affairs,
one of this country’s preeminent engines of medical innovation,”
added Zach Parker, DLH President and CEO. “Under this contract, DLH
may apply our digital transformation capabilities - spanning
artificial intelligence and machine learning, big data analytics,
telehealth, modeling and simulation, and more - towards improving
the advanced solutions available to Veterans, clinicians, and
caregivers.”
About DLHDLH (NASDAQ:DLHC) delivers improved
health and readiness solutions for federal programs through
research, systems development, and innovative care processes. The
Company’s experts in public health, performance evaluation, and
health operations solve the complex problems faced by civilian and
military customers alike, leveraging digital transformation,
artificial intelligence, advanced analytics, cloud-based
applications, telehealth systems, and more. With over 2,400
employees dedicated to the idea that “Your Mission is Our Passion,”
DLH brings a unique combination of government sector experience,
proven methodology, and unwavering commitment to public health to
improve the lives of millions. For more information, visit
www.DLHcorp.com.
Safe Harbor Statement under the Private Securities
Litigation Reform Act of 1995:This press release may
contain forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. These statements
relate to future events or DLH`s future financial performance. Any
statements that refer to expectations, projections or other
characterizations of future events or circumstances or that are not
statements of historical fact (including without limitation
statements to the effect that the Company or its management
“believes”, “expects”, “anticipates”, “plans”, “intends” and
similar expressions) should be considered forward looking
statements that involve risks and uncertainties which could cause
actual events or DLH’s actual results to differ materially from
those indicated by the forward-looking statements. Forward-looking
statements in this release include, among others, statements
regarding estimates of future revenues, operating income, earnings
and cash flow. These statements reflect our belief and assumptions
as to future events that may not prove to be accurate. Our actual
results may differ materially from such forward-looking statements
made in this release due to a variety of factors, including: the
outbreak of the novel coronavirus (“COVID-19”), including the
measures to reduce its spread, and its impact on the economy and
demand for our services, are uncertain, cannot be predicted, and
may precipitate or exacerbate other risks and uncertainties; the
risk that we will not realize the anticipated benefits of
acquisitions; the challenges of managing larger and more widespread
operations; contract awards in connection with re-competes for
present business and/or competition for new business; compliance
with new bank financial and other covenants; changes in client
budgetary priorities; government contract procurement (such as bid
and award protests, small business set asides, loss of work due to
organizational conflicts of interest, etc.) and termination risks;
the ability to successfully integrate the operations of
acquisitions; the impact of inflation and higher interest rates;
and other risks described in our SEC filings. For a discussion of
such risks and uncertainties which could cause actual results to
differ from those contained in the forward-looking statements, see
“Risk Factors” in the Company’s periodic reports filed with the
SEC, including our Annual Report on Form 10-K for the fiscal year
ended September 30, 2021, as well as subsequent reports filed
thereafter. The forward-looking statements contained herein are not
historical facts, but rather are based on current expectations,
estimates, assumptions and projections about our industry and
business.Such forward-looking statements are made as of the date
hereof and may become outdated over time. The Company does not
assume any responsibility for updating forward-looking statements,
except as may be required by law.
INVESTOR RELATIONSContact:
Chris WittyPhone: 646-438-9385Email: cwitty@darrowir.com
DLH (NASDAQ:DLHC)
Historical Stock Chart
From Jun 2024 to Jul 2024
DLH (NASDAQ:DLHC)
Historical Stock Chart
From Jul 2023 to Jul 2024